New research reveals that perimenopausal women are significantly contributing to the increased demand for GLP-1 medications, such as Ozempic, typically used for weight loss and diabetes management. This demographic is turning to these medications to manage weight changes often associated with menopause, thus highlighting a booming trend. The study underscores the importance of these medications in addressing the metabolic changes experienced by women during the perimenopausal phase. As interest grows, the market for these GLP-1 medications is expected to expand further, fueled by their dual benefits in weight management and diabetes care. Health providers have taken note of this trend, considering the implications for healthcare strategies targeting middle-aged women. Businesses in the pharmaceutical sector might see this as an opportunity to cater to a more nuanced market niche. Overall, these insights emphasize the potential for tailored healthcare solutions for women undergoing menopause.
AxiosNew data shows the most stolen vehicles in every state
May 4, 2026
A recent report published by BorderReport highlights troubling new data regarding vehicle theft across the United States, listing the most stolen vehicles in every state.